Background Over the decades, several natural history studies on patients with primary (PPMS) or secondary progressive multiple sclerosis (SPMS) were reported from international registries. In PPMS, a consistent heterogeneity on long-term disability trajectories was demonstrated. The aim of this study was to identify subgroups of patients with SPMS with similar longitudinal trajectories of disability over time. Methods All patients with MS collected within Big MS registries who received an SPMS diagnosis from physicians (cohort 1) or satisfied the Lorscheider criteria (cohort 2) were considered. Longitudinal Expanded Disability Status Scale (EDSS) scores were modelled by a latent class growth analysis (LCGA), using a non-linear function of t...
Multiple sclerosis is a long-term disease that evolves over a period of 30 to 40 years with progress...
Since the earliest clinical descriptions of multiple sclerosis (MS), it has been recognised that a m...
We report a natural history study of 216 patients with primary progressive (PP)- multiple sclerosis ...
Background Over the decades, several natural history studies on patients with primary (PPMS) or seco...
BACKGROUND: Over the decades, several natural history studies on patients with primary (PPMS) or sec...
Background: Several natural history studies on primary progressive multiple sclerosis (PPMS) patient...
Background: Several natural history studies on primary progressive multiple sclerosis (PPMS) patient...
Background: Primary progressive multiple sclerosis (PPMS) carries the worst prognosis of the multipl...
BACKGROUND: A minority of patients with multiple sclerosis (MS) have primary progressive disease (PP...
OBJECTIVES: To assess factors affecting the rate of conversion to secondary progressive (SP) multipl...
<div><p>Background</p><p>New agents with neuroprotective or neuroregenerative potential might be exp...
Multiple sclerosis can follow very different patterns of evolution and variable rates of disability ...
Rates of progression vary widely in primary progressive multiple sclerosis. This multicenter study a...
Multiple sclerosis is a long-term disease that evolves over a period of 30 to 40 years with progress...
Since the earliest clinical descriptions of multiple sclerosis (MS), it has been recognised that a m...
We report a natural history study of 216 patients with primary progressive (PP)- multiple sclerosis ...
Background Over the decades, several natural history studies on patients with primary (PPMS) or seco...
BACKGROUND: Over the decades, several natural history studies on patients with primary (PPMS) or sec...
Background: Several natural history studies on primary progressive multiple sclerosis (PPMS) patient...
Background: Several natural history studies on primary progressive multiple sclerosis (PPMS) patient...
Background: Primary progressive multiple sclerosis (PPMS) carries the worst prognosis of the multipl...
BACKGROUND: A minority of patients with multiple sclerosis (MS) have primary progressive disease (PP...
OBJECTIVES: To assess factors affecting the rate of conversion to secondary progressive (SP) multipl...
<div><p>Background</p><p>New agents with neuroprotective or neuroregenerative potential might be exp...
Multiple sclerosis can follow very different patterns of evolution and variable rates of disability ...
Rates of progression vary widely in primary progressive multiple sclerosis. This multicenter study a...
Multiple sclerosis is a long-term disease that evolves over a period of 30 to 40 years with progress...
Since the earliest clinical descriptions of multiple sclerosis (MS), it has been recognised that a m...
We report a natural history study of 216 patients with primary progressive (PP)- multiple sclerosis ...